FIELD: biochemistry.
SUBSTANCE: present invention relates to biochemistry, namely to immunogenic compositions against HIV-1, containing pharmaceutically acceptable carrier and antigenic peptide, selected from group consisting of PWNASASNKSLDDIW, PWNASWANKSLDDIW, PWNASWSAKSLDDIW and PWNASWSNKALDDIW. Said antigenic peptide can be covalently bound to carrier-molecule. Present invention also discloses method of using said antigenic peptides for detecting antibodies to above antigenic peptides in sample and kit, containing said antigenic peptides, for implementation of said method. Method involves contacting antigenic peptides, according to invention, with sample and detection of formation of complexes between said antigenic peptides and antibodies. Present invention also discloses method and kit for quantitative determination of antibodies to antigenic peptides, according to invention.
EFFECT: present invention widens range of products for treating or preventing infection, caused by HIV-1.
12 cl, 6 dwg, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBODY OR FRAGMENT THEREOF, HAVING NEUTRALISING EFFECT ON HIV, BUT NOT ON IL2 | 2005 |
|
RU2393873C2 |
| ANTIBODY OR FRAGMENT THEREOF WITH HIV-NEUTRALISING ACTIVITY | 2005 |
|
RU2380378C2 |
| METHOD FOR THE PROGNOSIS OF PROGRESSION OF THE HIV DISEASE | 2012 |
|
RU2601379C2 |
| RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS | 2012 |
|
RU2603732C2 |
| VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2648791C2 |
| gp41-NEUTRALIZING ANTIBODIES AND THEIR APPLICATION | 2012 |
|
RU2624046C2 |
| VACCINE AGAINST HIV/AIDS | 2010 |
|
RU2475264C2 |
| NEW Tat-COMPLEXES AND VACCINES CONTAINING THEM | 2005 |
|
RU2432356C2 |
